{
    "code": "52027437",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52027437",
    "time": "2019-04-26 03:07:45",
    "許可證字號": "衛部藥輸字第027437號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "112\/05\/18",
    "發證日期": "107\/05\/18",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202743707",
    "中文品名": "立肺治凍晶注射劑 1.5 毫克",
    "英文品名": "VELETRI Lyophilized Powder for Injection 1.5 mg",
    "適應症": "適用於治療結締組織疾病續發肺動脈高血壓之WHO功能分級III和IV的患者，以改善運動能力",
    "劑型": "243凍晶注射劑",
    "包裝": "一百支以下玻璃小瓶裝盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "EPOPROSTENOLSODIUM"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "1507401100  嬌生股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F259099000  PATHEON ITALIA S.P.A.",
        "製造廠廠址": "VIALE G.B. STUCCHI, 110-20900 MONZA (MB), ITALY",
        "製造廠公司地址": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2012102710",
            "成分名稱": "EPOPROSTENOL SODIUM",
            "含量描述": "",
            "含量": "1.5930000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "1. 仿單_VEL-PI-0.5-1.5-TW-1659 pp02 Approved for submission-107-09-21.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027437&Seq=001&Type=9"
        },
        {
            "title": "4. 外盒標籤_中文_1.5mg_VEL-ST-1,5-TW-1661 pp01 Approved for submission-107-09-21.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027437&Seq=003&Type=8"
        },
        {
            "title": "3. 瓶貼_1.5mg_222358 pp03 Approved-107-09-21.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027437&Seq=002&Type=8"
        },
        {
            "title": "2. 外盒_1.5mg_213126 pp02 approved-107-09-21.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027437&Seq=001&Type=8"
        }
    ]
}